^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    LstCAR019

    i
    Other names: LstCAR019, U-CAR-T Cells, Anti-CD19 Universal CAR-T Cells
    Associations

    News

    Trials
    Company:
    Chongqing Precision Biotech
    Drug class:
    CD19-targeted CAR-T immunotherapy
    Related drugs:
    Associations

    News

    Trials
    2years
    Anti-CD19 Universal CAR-T Cells for r/r CD19+ B-ALL (clinicaltrials.gov)
    P1/2, N=0, Withdrawn, Kunming Hope of Health Hospital | N=30 --> 0 | Recruiting --> Withdrawn
    Enrollment change • Trial withdrawal • CAR T-Cell Therapy
    |
    CD19 (CD19 Molecule)
    |
    CD19 expression
    |
    LstCAR019
    2years
    Anti-CD19 Universal CAR-T Cells for r/r CD19+ B-ALL (clinicaltrials.gov)
    P1/2, N=30, Recruiting, Kunming Hope of Health Hospital
    New P1/2 trial • CAR T-Cell Therapy
    |
    CD19 (CD19 Molecule)
    |
    CD19 expression
    |
    LstCAR019